Abstract:AIOLOS is a transcription factor of the IKAROS family, that is highly expressed in the lymphoid lineage and plays an important role in lymphocyte differentiation and development. Recently, two heterozygous AIOLOS germline mutations (G159R and N160S) were reported in primary immunodeficiency patients. Both variants associated distinctive and unique T and B cell differentiation defects, hematologic malignancies, and infectious disease susceptibility patterns through different dominant negative (DN) mechanisms. Here we report seven individuals from three unrelated families carrying AIOLOS variants Q402* (nonsense, 1 family) and E82K (missense, 2 families), leading to AIOLOS haploinsufficiency through different mechanisms of action. Clinically, patients with AIOLOS haploinsufficiency showed hypogammaglobulinemia, recurrent respiratory tract infections, and immune dysregulation manifested by autoimmunity and allergy, with incomplete clinical penetrance. Mechanistically, while the nonsense mutant Q402* is devoid of its C-terminal zinc-finger (ZF) dimerization domain (ZF5-6), it is still able to homodimerize with wildtype (WT) AIOLOS although unable to heterodimerize with WT IKAROS or HELIOS. We introduce new insights into AIOLOS biology as we found that AIOLOS ZF1, a part of AIOLOS DNA binding domain (ZF1-4), was associated with noncanonical dimerization and negative regulation of DNA binding. Further studies revealed that the mutant Q402* displayed abnormalities of DNA binding, pericentromeric targeting, post-transcriptional modification, and transcriptome regulation by haploinsufficiency. In contrast, mutant E82K showed overall normal AIOLOS functions; however, by affecting a newly defined AIOLOS protein stability domain, it also led to AIOLOS haploinsufficiency. Unlike the previously reported AIOLOS mutations, heterozygous variants Q402* and E82K do not have a DN effect over other IKAROS family proteins. Our data extend the spectrum of pathogenic variants of AIOLOS-associated diseases and provide a novel mechanism of homodimerization and protein stability that, when disrupted, could affect human health.

IKAROS—how many feathers have you lost: mild and severe phenotypes in IKZF1 deficiency

Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation

Ikaros is a principal regulator of Aire + mTEC homeostasis, thymic mimetic cell diversity, and central tolerance

The Clinical Impact of IKZF1 Mutation in Acute Myeloid Leukemia

Multifaceted roles of IKZF1 gene, perspectives from bench to bedside

Identification and Functional Analysis of a de novo IKZF3 Mutation in a Pediatric Patient with Combined Immunodeficiency

AIOLOS haploinsufficiency is associated with immunodeficiency, autoimmunity, and allergy

IgG4-related disease and B-cell malignancy due to an IKZF1 gain-of-function variant

Loss-of-phosphorylation of IKZF1 results in gain-of-function associated with immune dysregulation

AIOLOS-Associated Inborn Errors of Immunity

Point Mutations and Deletions in the Znfn1a1/ikaros Gene in Chemically Induced Murine Lymphomas.

Ikaros Proteins in Tumor: Current Perspectives and New Developments

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance

IKZF1 in acute lymphoblastic leukemia: the rise before the fall?

Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia

Ikzf1: A Critical Role in the Pathogenesis of Systemic Lupus Erythematosus?

Germline Genetic Variation in IKZF1 and Predisposition to Childhood Acute Lymphoblastic Leukemia

Neutrophilic dermatosis in a patient with an IKZF1 variant and a review of monogenic autoinflammatory disorders presenting with neutrophilic dermatoses

Helios—Illuminating the way for lymphocyte self‐control

Ikaros Deletions among Bulgarian Patients with Acute Lymphoblastic Leukemia/Lymphoma

Serine Phosphorylation by SYK is Critical for Nuclear Localization and Transcription Factor Function of Ikaros